X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (89) 89
Book / eBook (19) 19
Book Review (8) 8
Publication (8) 8
Book Chapter (3) 3
Conference Proceeding (2) 2
Dissertation (2) 2
Newspaper Article (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (45) 45
humans (37) 37
male (34) 34
female (30) 30
middle aged (26) 26
adult (22) 22
gastroenterology & hepatology (22) 22
hepatitis c (19) 19
abridged index medicus (17) 17
antiviral agents - therapeutic use (16) 16
hepacivirus - genetics (16) 16
hepatitis c virus (15) 15
aged (14) 14
hepatitis c, chronic - drug therapy (14) 14
drug therapy, combination (13) 13
gastroenterology and hepatology (12) 12
genotype (12) 12
health aspects (12) 12
antiviral agents - adverse effects (11) 11
ribavirin (11) 11
animals (10) 10
antiviral agents (10) 10
care and treatment (10) 10
genetic aspects (10) 10
liver (10) 10
hepatitis (9) 9
research (9) 9
drug therapy (8) 8
history (8) 8
medicine, general & internal (8) 8
resistance (8) 8
sofosbuvir - therapeutic use (8) 8
young adult (8) 8
aged, 80 and over (7) 7
antiviral agents - administration & dosage (7) 7
biography (7) 7
cirrhosis (7) 7
genotypes (7) 7
sofosbuvir (7) 7
treatment outcome (7) 7
adolescent (6) 6
allergy (6) 6
benzimidazoles - therapeutic use (6) 6
hcv (6) 6
hepatitis c, chronic - virology (6) 6
interferon (6) 6
liver cirrhosis (6) 6
ribavirin - therapeutic use (6) 6
viral nonstructural proteins - antagonists & inhibitors (6) 6
age (5) 5
benzimidazoles - adverse effects (5) 5
carbamates - therapeutic use (5) 5
clinical trials (5) 5
combination (5) 5
daa (5) 5
drug combinations (5) 5
genotype & phenotype (5) 5
hepatitis c - drug therapy (5) 5
hepatology (5) 5
heterocyclic compounds, 4 or more rings - therapeutic use (5) 5
immunology (5) 5
medicine & public health (5) 5
patients (5) 5
prevalence (5) 5
prevention (5) 5
protease inhibitors (5) 5
proteases (5) 5
risk factors (5) 5
rna, viral - blood (5) 5
sofosbuvir - adverse effects (5) 5
studies (5) 5
sulfonamides - therapeutic use (5) 5
therapy (5) 5
allergens (4) 4
analysis (4) 4
article (4) 4
carbamates - adverse effects (4) 4
clinical trial (4) 4
consumption (4) 4
dosage and administration (4) 4
drug administration schedule (4) 4
english literature (4) 4
epidemiology (4) 4
fairy tales (4) 4
fluorenes - therapeutic use (4) 4
food (4) 4
france (4) 4
hepacivirus - drug effects (4) 4
hepatitis c - virology (4) 4
ige (4) 4
immunoglobulin e (4) 4
infection (4) 4
infections (4) 4
interferon-alpha - therapeutic use (4) 4
internal medicine (4) 4
medical research (4) 4
medicine (4) 4
new zealand (4) 4
new zealand - epidemiology (4) 4
proteins (4) 4
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (8) 8
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Gerstein Science - Reference (2) 2
UofT at Scarborough - Stacks (2) 2
Victoria University E.J. Pratt - Rare Book (2) 2
OISE - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ANNALS OF INTERNAL MEDICINE, ISSN 0003-4819, 12/2015, Volume 163, Issue 11, pp. 809 - 817
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9751, pp. 1467 - 1475
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 27, pp. 2608 - 2617
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 8, pp. 705 - 713
Among patients coinfected with HIV-1 and HCV genotype 1 or 4 who were receiving effective antiretroviral therapy, treatment with 12 weeks of ledipasvir and... 
MEDICINE, GENERAL & INTERNAL | HEPATOCELLULAR-CARCINOMA | INTERFERON | THERAPY | HEPATITIS-C VIRUS | CIRRHOSIS | ALPHA-2A PLUS RIBAVIRIN | VETERANS | GENOTYPE 1 INFECTION | COHORT | LIVER-DISEASE | HIV-1 | Humans | Middle Aged | Drug Resistance, Viral | Fluorenes - therapeutic use | Hepacivirus - genetics | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Viral Load | Female | Fluorenes - adverse effects | Uridine Monophosphate - adverse effects | Benzimidazoles - adverse effects | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Fluorenes - pharmacokinetics | Hepacivirus - isolation & purification | Anti-Retroviral Agents - therapeutic use | Antiviral Agents - therapeutic use | Benzimidazoles - pharmacokinetics | Genotype | Hepatitis C, Chronic - drug therapy | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | HIV Infections - complications | HIV Infections - drug therapy | Uridine Monophosphate - pharmacokinetics | Sofosbuvir | Care and treatment | Research | Hepatitis C virus | HIV infection | Emtricitabine | Headache | Antiretroviral drugs | Inhibitor drugs | Diarrhea | Fatigue | Patients | Efavirenz | Studies | Tenofovir | Cirrhosis | Genotype & phenotype | Hepatitis | Human immunodeficiency virus--HIV | Hepatitis C | Drug therapy | Genotypes | Index Medicus | Abridged Index Medicus
Journal Article
Hepatology, ISSN 0270-9139, 04/2013, Volume 57, Issue 4, pp. 1677 - 1678
Journal Article
Hepatology, ISSN 0270-9139, 04/2013, Volume 57, Issue 4, p. 1677
Journal Article
Hepatology, ISSN 0270-9139, 04/2013, Volume 57, Issue 4, pp. 1677 - 1678
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 153, Issue 1, pp. 113 - 122
Abstract Background & Aims Patients with chronic hepatitis C virus (HCV) infection have high rates of sustained virologic response (SVR) following 12 weeks of... 
Gastroenterology and Hepatology | Direct-Acting Antiviral Agent | Shortened Duration Therapy | Clinical Trial | Comparison | PROTEASE INHIBITOR GS-9857 | SIMEPREVIR PLUS SOFOSBUVIR | COMBINATION | CHALLENGES | GENOTYPE 1 | TREATMENT-NAIVE | THERAPY | HEPATITIS-C VIRUS | CIRRHOSIS | DIRECT-ACTING ANTIVIRALS | GASTROENTEROLOGY & HEPATOLOGY | Humans | Middle Aged | Male | Carbamates - administration & dosage | Young Adult | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Aged, 80 and over | Adult | Female | Sofosbuvir - adverse effects | Drug Therapy, Combination | Heterocyclic Compounds, 4 or More Rings - administration & dosage | Sofosbuvir - therapeutic use | Antiviral Agents - therapeutic use | Heterocyclic Compounds, 4 or More Rings - adverse effects | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Macrocyclic Compounds - therapeutic use | Sofosbuvir - administration & dosage | Sulfonamides - therapeutic use | Antiviral Agents - adverse effects | Adolescent | Sulfonamides - adverse effects | Carbamates - adverse effects | Aged | Macrocyclic Compounds - administration & dosage | Sustained Virologic Response | Carbamates - therapeutic use | Sulfonamides - administration & dosage | Medical colleges | Care and treatment | Protease inhibitors | Proteases | Transplantation of organs, tissues, etc | Product development | Hepatitis C virus | Hepatitis C | Health aspects | Analysis | Index Medicus | Abridged Index Medicus
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 151, Issue 5, pp. 902 - 909
Journal Article
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2005, Volume 102, Issue 6, pp. 2063 - 2068
Cholestasis is associated with accumulation of bile acids and lipids, and liver injury. The constitutive androstane receptor (CAR) and pregnane X receptor... 
Biological Sciences | Receptors | Bile acids | Liver | HDL lipoproteins | Mice | Automobiles | Cholesterols | Cholestasis | Genotypes | Bile | High-density lipoprotein | Bile acid | Cholesterol | XENOBIOTIC RESPONSE | BILE-ACID DETOXIFICATION | bile acid | TRANSPORTER EXPRESSION | high-density lipoprotein | MULTIDISCIPLINARY SCIENCES | LITHOCHOLIC ACID | CYP3A4 | cholestasis | PRIMARY BILIARY-CIRRHOSIS | GENE-EXPRESSION | cholesterol | MICE | TRANSCRIPTIONAL REGULATION | DRUG-METABOLISM | Liver - pathology | Receptors, Steroid - metabolism | Cholestasis - metabolism | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Male | Gene Expression Profiling | Solute Carrier Organic Anion Transporter Family Member 1b1 - genetics | Organic Cation Transport Proteins - metabolism | Liver - metabolism | Gene Expression Regulation | Bile Acids and Salts - metabolism | Lipid Metabolism | Receptors, Cytoplasmic and Nuclear - genetics | Bile Ducts - surgery | Transcription Factors - genetics | Cholesterol - metabolism | Mice, Inbred Strains | Mice, Knockout | Transcription Factors - metabolism | Cholestasis - pathology | Animals | Receptors, Steroid - genetics | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Solute Carrier Organic Anion Transporter Family Member 1b1 - metabolism | Liver - cytology | Organic Cation Transport Proteins - genetics | Receptors, Cytoplasmic and Nuclear - metabolism | Care and treatment | Jaundice, Obstructive | Liver diseases | Causes of | Research | Mice as laboratory animals | Medical research | Pharmacology | Gene expression | Rodents | Index Medicus
Journal Article